Hydrapres S.A. (WSE:HPS)

Hydrapres Statistics

Total Valuation

Hydrapres has a market cap or net worth of PLN 23.29 million. The enterprise value is 36.85 million.

Market Cap	23.29M
Enterprise Value	36.85M

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

Hydrapres has 52.93 million shares outstanding.

Current Share Class	52.93M
Shares Outstanding	52.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	18.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	3.19
P/TBV Ratio	3.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.30
EV / Sales	1.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.61

Financial Position

The company has a current ratio of 2.28, with a Debt / Equity ratio of 2.01.

Current Ratio	2.28
Quick Ratio	1.26
Debt / Equity	2.01
Debt / EBITDA	n/a
Debt / FCF	-3.44
Interest Coverage	-4.33

Financial Efficiency

Return on equity (ROE) is -90.85% and return on invested capital (ROIC) is -20.64%.

Return on Equity (ROE)	-90.85%
Return on Assets (ROA)	-9.38%
Return on Invested Capital (ROIC)	-20.64%
Return on Capital Employed (ROCE)	-19.44%
Weighted Average Cost of Capital (WACC)	5.16%
Revenue Per Employee	326,993
Profits Per Employee	-63,592
Employee Count	92
Asset Turnover	1.03
Inventory Turnover	4.13

Taxes

Income Tax	-1,699
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.98% in the last 52 weeks. The beta is 0.13, so Hydrapres's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-5.98%
50-Day Moving Average	0.46
200-Day Moving Average	0.51
Relative Strength Index (RSI)	46.77
Average Volume (20 Days)	1,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hydrapres had revenue of PLN 30.08 million and -5.85 million in losses.

Revenue	30.08M
Gross Profit	371,810
Operating Income	-4.40M
Pretax Income	-5.85M
Net Income	-5.85M
EBITDA	-2.94M
EBIT	-4.40M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 1.16 million in cash and 14.71 million in debt, with a net cash position of -13.56 million or -0.26 per share.

Cash & Cash Equivalents	1.16M
Total Debt	14.71M
Net Cash	-13.56M
Net Cash Per Share	-0.26
Equity (Book Value)	7.30M
Book Value Per Share	n/a
Working Capital	8.53M

Cash Flow

In the last 12 months, operating cash flow was -3.58 million and capital expenditures -702,000, giving a free cash flow of -4.28 million.

Operating Cash Flow	-3.58M
Capital Expenditures	-702,000
Depreciation & Amortization	1.46M
Net Borrowing	-3.09M
Free Cash Flow	-4.28M
FCF Per Share	-0.08

Margins

Gross margin is 1.24%, with operating and profit margins of -14.63% and -19.45%.

Gross Margin	1.24%
Operating Margin	-14.63%
Pretax Margin	-19.45%
Profit Margin	-19.45%
EBITDA Margin	-9.79%
EBIT Margin	-14.63%
FCF Margin	n/a

Dividends & Yields

Hydrapres does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-25.12%
FCF Yield	-18.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3